187 related articles for article (PubMed ID: 37113782)
1. Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination.
Villanueva P; Crawford NW; Croda MG; Collopy S; Jardim BA; de Almeida Pinto Jardim T; Manning L; Lucas M; Marshall H; Prat-Aymerich C; Sawka A; Sharma K; Troeman D; Wadia U; Warris A; Wood N; Messina NL; Curtis N; Pittet LF
Heliyon; 2023 Apr; 9(4):e15241. PubMed ID: 37113782
[TBL] [Abstract][Full Text] [Related]
2. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial.
Pittet LF; Moore CL; McDonald E; Barry S; Bonten M; Campbell J; Croda J; Dalcolmo M; Davidson A; Douglas MW; Gardiner K; Gwee A; Jardim B; Lacerda MVG; Lucas M; Lynn DJ; Manning L; de Oliveira RD; Perrett KP; Prat-Aymerich C; Richmond PC; Rocha JL; Rodriguez-Baño J; Warris A; Wood NJ; Messina NL; Curtis N;
EClinicalMedicine; 2023 Oct; 64():102203. PubMed ID: 37719417
[TBL] [Abstract][Full Text] [Related]
3. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial.
Pittet LF; Messina NL; McDonald E; Orsini F; Barry S; Bonten M; Campbell J; Croda J; Croda MG; Dalcolmo M; Gardiner K; Gwee A; Jardim B; Lacerda MVG; Lucas M; Lynn DJ; Manning L; Perrett KP; Post JJ; Prat-Aymerich C; Richmond PC; Rocha JL; Rodriguez-Baño J; Warris A; Wood NJ; Davidson A; Curtis N;
EClinicalMedicine; 2024 Jun; 72():102616. PubMed ID: 38774675
[TBL] [Abstract][Full Text] [Related]
4. The association between Bacillus Calmette-Guérin vaccination (1331 SSI) skin reaction and subsequent scar development in infants.
Birk NM; Nissen TN; Ladekarl M; Zingmark V; Kjærgaard J; Jensen TM; Jensen SK; Thøstesen LM; Kofoed PE; Stensballe LG; Andersen A; Pryds O; Nielsen SD; Benn CS; Jeppesen DL
BMC Infect Dis; 2017 Aug; 17(1):540. PubMed ID: 28774269
[TBL] [Abstract][Full Text] [Related]
5. Determinants of Bacille Calmette-Guérin scarification in Danish children.
Jensen TM; Jensen SK; Birk NM; Rieckmann A; Hoffmann T; Benn CS; Jeppesen DL; Pryds O; Nissen TN
Heliyon; 2021 Jan; 7(1):e05757. PubMed ID: 33474505
[TBL] [Abstract][Full Text] [Related]
6. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
[TBL] [Abstract][Full Text] [Related]
7. Determinants of BCG scarification among children in rural Guinea-Bissau: A prospective cohort study.
Funch KM; Thysen SM; Rodrigues A; Martins CL; Aaby P; Benn CS; Fisker AB
Hum Vaccin Immunother; 2018; 14(10):2434-2442. PubMed ID: 29293396
[TBL] [Abstract][Full Text] [Related]
8. BCG scarring and improved child survival: a combined analysis of studies of BCG scarring.
Benn CS; Roth A; Garly ML; Fisker AB; Schaltz-Buchholzer F; Timmermann A; Berendsen M; Aaby P
J Intern Med; 2020 Dec; 288(6):614-624. PubMed ID: 32301189
[TBL] [Abstract][Full Text] [Related]
9. Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy.
Villanueva P; Wadia U; Crawford N; Messina NL; Kollmann TR; Lucas M; Manning L; Richmond P; Pittet LF; Curtis N
NPJ Vaccines; 2022 Jan; 7(1):6. PubMed ID: 35031617
[TBL] [Abstract][Full Text] [Related]
10. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
11. Maternal Priming: Bacillus Calmette-Guérin (BCG) Vaccine Scarring in Mothers Enhances the Survival of Their Child With a BCG Vaccine Scar.
Berendsen MLT; Øland CB; Bles P; Jensen AKG; Kofoed PE; Whittle H; de Bree LCJ; Netea MG; Martins C; Benn CS; Aaby P
J Pediatric Infect Dis Soc; 2020 Apr; 9(2):166-172. PubMed ID: 30715451
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports.
Mohamed L; Madsen AMR; Schaltz-Buchholzer F; Ostenfeld A; Netea MG; Benn CS; Kofoed PE
BMC Infect Dis; 2021 Dec; 21(1):1264. PubMed ID: 34930152
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination.
Villanueva P; Crawford NW; Croda MG; Collopy S; Jardim BA; de Almeida Pinto Jardim T; Manning L; Lucas M; Marshall H; Prat-Aymerich C; Sawka A; Sharma K; Troeman D; Wadia U; Warris A; Wood N; Messina NL; Curtis N; Pittet LF
Heliyon; 2023 Jun; 9(6):e15821. PubMed ID: 37484338
[TBL] [Abstract][Full Text] [Related]
14. A case series of bacillus Calmette-Guérin scar reactivation after administration of both mRNA and viral vector COVID-19 vaccines.
van Balveren L; van Puijenbroek EP; Davidson L; van Hunsel F
Br J Clin Pharmacol; 2023 Jul; 89(7):2113-2121. PubMed ID: 36717367
[TBL] [Abstract][Full Text] [Related]
15. Bacille Calmette-Guérin vaccination is associated with lower prevalence of allergic diseases in Indian children.
Singh M; Das RR; Kumar L; Kumar R
Am J Rhinol Allergy; 2013; 27(4):e107-12. PubMed ID: 23883802
[TBL] [Abstract][Full Text] [Related]
16. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
[TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe.
Geldenhuys HD; Mearns H; Foster J; Saxon E; Kagina B; Saganic L; Jarrahian C; Tameris MD; Dintwe OB; Van Rooyen M; Luabeya KK; Hussey G; Scriba TJ; Hatherill M; Zehrung D
Vaccine; 2015 Sep; 33(37):4719-26. PubMed ID: 25862299
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of bacillus Calmette-Guérin scar formation and tuberculin skin test reactivity in infants in Lima, Peru.
Santiago EM; Lawson E; Gillenwater K; Kalangi S; Lescano AG; Du Quella G; Cummings K; Cabrera L; Torres C; Gilman RH
Pediatrics; 2003 Oct; 112(4):e298. PubMed ID: 14523215
[TBL] [Abstract][Full Text] [Related]
19. BCG scar and tuberculin reactivity in children and adults.
Fjällbrant H; Ridell M; Larsson LO
Scand J Infect Dis; 2008; 40(5):387-92. PubMed ID: 18418799
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.
Sinha S; Ajayababu A; Thukral H; Gupta S; Guha SK; Basu A; Gupta G; Thakur P; Lingaiah R; Das BK; Singh UB; Singh R; Narang R; Bhowmik D; Wig N; Modak DC; Bandyopadhyay B; Chakrabarty B; Kapoor A; Tewari S; Prasad N; Hashim Z; Nath A; Kumari N; Goswami R; Pandey S; Pandey RM
Infect Dis Ther; 2022 Dec; 11(6):2205-2217. PubMed ID: 36242739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
